Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-08 5:06 pm Sale | 2024-05-06 | 13D | GlycoMimetics, Inc. GLYC | New Enterprise Associates 10, Limited Partnership | 21,819 5.000% | -18,261 (-45.56%) | Filing History |
| 2024-02-29 7:28 pm Sale | 2024-02-06 | 13D | GlycoMimetics, Inc. GLYC | New Enterprise Associates 10, Limited Partnership | 40,080 6.200% | -7,139 (-15.12%) | Filing History |
| 2024-02-12 4:48 pm Sale | 2024-02-06 | 13D | GlycoMimetics, Inc. GLYC | New Enterprise Associates 10, Limited Partnership | 47,219 7.300% | -43,895 (-48.18%) | Filing History |
| 2024-02-09 5:03 pm Purchase | 2023-12-31 | 13G | GlycoMimetics, Inc. GLYC | Artal Participations S.a r.l | 85,891 13.300% | 20,153 (+30.66%) | Filing History |
| 2024-01-29 4:31 pm Unchanged | 2023-03-29 | 13G | GlycoMimetics, Inc. GLYC | BIOTECHNOLOGY VALUE FUND L P | 95,443 14.800% | 0 (Unchanged) | Filing History |
| 2023-02-13 5:18 pm Purchase | 2023-02-09 | 13G | GlycoMimetics, Inc. GLYC | Artal Participations S.a r.l | 65,738 12.500% | 65,738 (New Position) | Filing History |
| 2023-02-10 5:23 pm Purchase | 2023-01-26 | 13D | GlycoMimetics, Inc. GLYC | New Enterprise Associates 10, Limited Partnership | 49,675 9.500% | 49,675 (New Position) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | GlycoMimetics, Inc. GLYC | The Vanguard Group | 22,386 4.330% | -3,307 (-12.87%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | GlycoMimetics, Inc. GLYC | BlackRock Inc. BLK | 8,861 1.700% | -17,303 (-66.13%) | Filing History |
| 2021-02-16 08:24 am Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | Camber Capital Management LP | 22,000 4.600% | -13,000 (-37.14%) | Filing History |
| 2021-02-12 3:42 pm Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | EcoR1 Capital, LLC | 0 0.000% | -29,098 (Position Closed) | Filing History |
| 2021-02-11 5:14 pm Purchase | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | BIOTECHNOLOGY VALUE FUND L P | 95,443 19.960% | 21,825 (+29.65%) | Filing History |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | The Vanguard Group | 25,692 5.370% | 25,692 (New Position) | Filing History |
| 2021-01-29 09:57 am Sale | 2020-12-31 | 13G | GlycoMimetics, Inc. GLYC | BlackRock Inc. BLK | 26,165 5.500% | -2,120 (-7.50%) | Filing History |